Last reviewed · How we verify
ato-oxy
Ato-oxy is an oxygen-based therapeutic that enhances tissue oxygenation to promote wound healing and tissue repair.
Ato-oxy is an oxygen-based therapeutic that enhances tissue oxygenation to promote wound healing and tissue repair. Used for Chronic wounds and diabetic foot ulcers.
At a glance
| Generic name | ato-oxy |
|---|---|
| Also known as | atomoxetine and oxybutynin |
| Sponsor | University of Arizona |
| Drug class | Oxygen therapeutic |
| Modality | Small molecule |
| Therapeutic area | Wound Care / Dermatology |
| Phase | FDA-approved |
Mechanism of action
The drug works by improving oxygen delivery and utilization in hypoxic tissues, which stimulates angiogenesis, collagen deposition, and cellular proliferation necessary for wound healing. This mechanism is particularly relevant in chronic wounds where tissue hypoxia impairs the natural healing cascade.
Approved indications
- Chronic wounds and diabetic foot ulcers
Common side effects
Key clinical trials
- Endotype DIrected Treatment for OSA in Down Syndrome (PHASE4)
- Medications for Obstructive Sleep Apnea In Children With Down Syndrome (PHASE2)
- Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |